Rankings
▼
Calendar
CGEM FY 2025 Earnings — Cullinan Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
CGEM
Cullinan Therapeutics, Inc.
$894M
FY 2025 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$242M
Net Income
-$220M
EPS (Diluted)
$0.00
Cash Flow
Operating Cash Flow
-$176M
Free Cash Flow
-$176M
Stock-Based Comp.
$36M
Balance Sheet
Total Assets
$448M
Total Liabilities
$40M
Stockholders' Equity
$409M
Cash & Equivalents
$88M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$306,000
+100.0%
Operating Income
-$242M
-$197M
-22.7%
Net Income
-$220M
-$167M
-31.4%
← Q4 2024
All Quarters
Q1 2025 →